Publications by authors named "Cindy McCoig"
Article Synopsis
- - Cabotegravir + rilpivirine is a new long-acting antiretroviral therapy given monthly or every two months, but the COVID-19 pandemic disrupted many patients' clinic visits for injections.
- - A study evaluated how well the treatment was maintained during the pandemic across various clinical trials, finding that 94% of participants continued their planned dosing without major issues despite some visits being affected.
- - Most of the 130 affected participants switched to oral therapy to ensure continued treatment, with 98% maintaining effective viral suppression, highlighting the flexibility of the treatment approach during the pandemic.
The emergence of multidrug-resistant strains of Streptococcus pneumoniae drives the development and evaluation of new antipneumococcal agents, especially for the treatment of bacterial meningitis. The aims of the present study were to assess the antibacterial effectiveness of two new quinolones, garenoxacin (BMS; BMS-284756) and moxifloxacin (MOX) in experimental meningitis caused by a vancomycin (VAN)-tolerant S. pneumoniae strain and to compare the results with those obtained by therapy with VAN and ceftriaxone (CRO) in combination.
View Article and Find Full Text PDF